title: Primary in situ immune response in popliteal lymph nodes and spleen of mice after subcutaneous immunization with thymus-dependent or thymus-independent (type 1 and 2) antigens.
abstract: Mice were immunized subcutaneously with thymus-independent (TI)-type 1 antigen trinitrophenylated lipopolysaccharide (TNP-LPS), TI-type 2 antigen TNP-Ficoll or thymus-dependent (TD) antigen TNP-keyhole limpet haemocyanin (TNP-KLH) in order to study the primary in situ immune response in popliteal lymph nodes (PLN) and spleen. The spleen responded more rapidly in developing specific antibody-forming cells (AFC) than the lymph nodes did, in spite of the fact that antigens reach the spleen only after passing several lymph node stations. This difference between lymph nodes and spleen in developing AFC was particularly significant with respect to the responses to TI (both type 1 and type 2) antigens. No differences in the distribution of specific AFC in PLN and spleen were observed after immunization with TI and TD antigens. Results are discussed with respect to the relative contributions of lymph nodes and spleen to immune responses to antigens injected subcutaneously.
authors.affiliation: Department of Histology, Medical Faculty, Free University, Amsterdam, The Netherlands.
authors.forename: F G
authors.initials: FG
authors.lastname: Delemarre
authors.forename: E
authors.initials: E
authors.lastname: Claassen
authors.forename: N
authors.initials: N
authors.lastname: Van Rooijen
mesh_terms: D000818:Animals; D000921:Antibody-Producing Cells / Q000276:immunology; D000936:Antigen-Antibody Complex / Q000276:immunology; D000955:Antigens, T-Independent / Q000008:administration & dosage / Q000276:immunology*; D005362:Ficoll / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000276:immunology*; D006241:Haptens; D006433:Hemocyanins / Q000008:administration & dosage / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006651:Histocytochemistry; D007114:Immunization / Q000379:methods; D007279:Injections, Subcutaneous / Q000379:methods; D007719:Knee Joint / Q000033:anatomy & histology*; D008070:Lipopolysaccharides / Q000008:administration & dosage / Q000276:immunology*; D008198:Lymph Nodes / Q000276:immunology*; D008297:Male; D051379:Mice; D009578:Nitrobenzenes / Q000276:immunology*; D011134:Polysaccharides / Q000276:immunology*; D013154:Spleen / Q000166:cytology / Q000276:immunology* / Q000502:physiology; D014301:Trinitrobenzenes / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D000936:Antigen-Antibody Complex; D000955:Antigens, T-Independent; D006241:Haptens; D000949:Histocompatibility Antigens Class II; D008070:Lipopolysaccharides; D009578:Nitrobenzenes; D011134:Polysaccharides; C020529:TNP-ficoll; D014301:Trinitrobenzenes; C054401:trinitrophenyl keyhole limpet hemocyanin; C048761:trinitrophenyl-lipopolysaccharide; D005362:Ficoll; D006433:Hemocyanins